Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract Awards
Help
Definitive Contract HHSO100201600023C
Award Date
8/9/16
Potential Completion Date
9/30/22
Potential Value
$11M
Overview
AI Insights
Buyer Personas
Industry Personas
Buyer Personas In this Market
5
Activity
6
Transactions
6
Subawards
Opportunity Stack
1
Federal Agency
Office of the Assistant Secretary for Preparedness and Response
Awardee
Regeneron Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AN11 - Health R&D Services; Health Care Services; Basic Research
Federal Contract Vehicle
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Sleepy Hollow, NY 10591, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Description
Update #1
Posted 8/12/16, 12:00 AM
Name
Description
Solicitation Number
Federal Agency
Type
Posted Date
(Click to sort descending)
Broad Agency Announcement (BAA) for the Advanced Development of Medical Countermeasures for Pandemic Influenza
Added: Oct 01, 2015 11:16 pm Synopsis: BARDA encourages the advanced research, development and acquisition of medical countermeasures such as vaccines, therapeutics, and diagnostics, as well as innovative approaches to meet the threat of Pandemic Influenza in support of the preparedness mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) articulated in the 2014 PHEMCE Implementation Plan. The Implementation Plan is located on the ASPR website: http://www.phe.gov/Preparedness/mcm/phemce/Documents/2014-phemce-sip.pdfThe Pandemic and All Hazard Preparedness Act Pub. L. No. 109-417, 42 U.S.C. § 241 et seq. (PAHPA; http://www.gpo.gov/fdsys/pkg/PLAW-109publ417/pdf/PLAW-109publ417.pdf) and The Pandemic and All Hazard Preparedness Reauthorization Act Pub. L. No. 113-5, (PAHPRA: http://www.gpo.gov/fdsys/pkg/PLAW-113publ5/pdf/PLAW-113publ5.pdf) authorizes BARDA to (i) conduct ongoing searches for, and support calls for, potential qualified countermeasures and qualified pandemic or epidemic products; (ii) direct and coordinate the countermeasure and product advanced research and development activities of the Department of Health and Human Services; (iii) establish strategic initiatives to accelerate countermeasure and product advanced research and development (which may include advanced research and development for purposes of fulfilling requirements under the Federal Food, Drug, and Cosmetic Act or section 351 of this Act) and innovation in such areas as the Secretary may identify as priority unmet need areas; and (iv) award contracts, grants, cooperative agreements, and enter into other transactions, for countermeasure and product advanced research and development.Development Area of Interest:The purpose of this BAA is to solicit proposals that focus on one or more of the following area of interest as listed below:Development Area of Interest• Personal Protective Equipment (Mask and Respirators) for Influenza Infection for All- Hazards• Full-Featured Continuous Ventilators for Influenza and All-Hazards• Influenza Test Systems and Diagnostic Tools• Influenza Therapeutics• Influenza VaccinesBARDA anticipates that research and development activities awarded from this Broad Agency Announcement (BAA) will serve to advance the knowledge and scientific understanding of candidates' to protect the civilian population of the United States against pandemic influenza and serve to advance candidate medical countermeasures towards licensure or approval by the Food and Drug Administration (FDA).The Government intends to promote full & open competition for this requirement in the form of a BAA. This synopsis is not a BAA; BAA solicitation no. BAA-16-100-SOL-00002 is anticipated to be posted on or about October 13, 2015. The Government expects to make 1 or more awards, subject to the availability of funds. The open period of the BAA will be specified in the BAA. This advertisement does not commit the Government to award a contract.Contact Information:Technical Point of Contact - Chuong Huynh, Chuong.Huynh@hhs.govComments to this announcement, referencing synopsis of BAA- 16-100-SOL-00002 may be submitted to email address Flu-BAA@hhs.gov.Contracting Office Address:Department of Health & Human Services (DHHS)Office of the Assistant Secretary for Preparedness & Response (ASPR) Acquisition Management Contracts & Grants (AMCG)330 Independence Ave., S.W., Room G-644Washington, D.C. 20201Pre-proposal Conference:A Multi-BAA Pre-Proposal Conference will be held in Washington, DC on October 14-16, 2015. Advance registration is required. For additional information, and to register, please visit: https://www.medicalcountermeasures.gov/federal-initiatives/public-meetings-and-conferences/barda-industry-day-2015
BAA-16-100-SOL-00002
Department of Health and Human Services Immediate Office of the Secretary
Award Notice 1/1
10/1/15, 11:16 PM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
P00005
THE PURPOSE OF THIS MODIFICATION 5 (FIVE) TO THE CONTRACT IS TO ACCOMPLISH THE FOLLOWING: 1.) EXTEND THE PERIOD OF PERFORMANCE, AT NO ADDITIONAL COST TO THE GOVERNMENT, FROM 8/15/2016 THROUGH 9/30/2019 TO 8/15/2016 THROUGH 9/30/2022 TO INCREASE LE
Change Order
$0
9/27/19
4
Change Order
$0
6/28/17
3
Other Administrative Action
$0
1/12/17
2
Other Administrative Action
$7.2m
11/23/16
1
Exercise an Option
$0
8/19/16